MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

Search

AmerisourceBergen Corporation

Cerrado

SectorSalud

0

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Métricas clave

By Trading Economics

Ingresos

-1B

-340M

Ventas

3.1B

84B

P/B

Media del Sector

42.931

90.831

BPA

3.84

Rentabilidad por dividendo

0.66

Margen de beneficio

-0.406

Empleados

47,000

EBITDA

-1.1B

150M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+16.99% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.66%

2.20%

Próximas Ganancias

4 feb 2026

Fecha Próximo Dividendo

2 mar 2026

Próxima Fecha de Ex Dividendo

13 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

278M

66B

Apertura anterior

0

Cierre anterior

0

Noticias sobre sentimiento de mercado

By Acuity

17%

83%

31 / 361 Clasificación en Healthcare

AmerisourceBergen Corporation Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

13 ene 2026, 19:05 UTC

Principales Movimientos del Mercado

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 ene 2026, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 ene 2026, 23:41 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 ene 2026, 23:33 UTC

Charlas de Mercado

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 ene 2026, 23:13 UTC

Adquisiciones, fusiones, absorciones

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 ene 2026, 23:10 UTC

Adquisiciones, fusiones, absorciones

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 ene 2026, 23:03 UTC

Charlas de Mercado

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 ene 2026, 21:50 UTC

Adquisiciones, fusiones, absorciones

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 ene 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 ene 2026, 21:15 UTC

Adquisiciones, fusiones, absorciones

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 ene 2026, 21:08 UTC

Adquisiciones, fusiones, absorciones

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 ene 2026, 20:39 UTC

Charlas de Mercado

Silver Settles at Another New High -- Market Talk

13 ene 2026, 20:21 UTC

Charlas de Mercado

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 ene 2026, 20:17 UTC

Charlas de Mercado

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 ene 2026, 19:08 UTC

Adquisiciones, fusiones, absorciones

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 ene 2026, 19:03 UTC

Ganancias

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 ene 2026, 18:50 UTC

Ganancias

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 ene 2026, 17:54 UTC

Charlas de Mercado

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 ene 2026, 17:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

13 ene 2026, 17:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 ene 2026, 17:49 UTC

Charlas de Mercado

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 ene 2026, 17:38 UTC

Charlas de Mercado

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

13 ene 2026, 17:19 UTC

Charlas de Mercado

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 ene 2026, 17:15 UTC

Charlas de Mercado

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Comparación entre iguales

Cambio de precio

AmerisourceBergen Corporation Esperado

Precio Objetivo

By TipRanks

16.99% repunte

Estimación a 12 meses

Media 400.3 USD  16.99%

Máximo 440 USD

Mínimo 360 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AmerisourceBergen Corporation Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

9

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

31 / 361 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat